Shows
State of Medtech425.a16z State of Markets 2026: Why MedTech Could Be the Next Big Investment Opportunitya16z says physical technology is becoming important again. What could that mean for MedTech?Omar Khateeb analyzes a16z’s State of Markets 2026 report and explores how AI, robotics, infrastructure, and changing venture economics could reshape the investment case for medical technology.One theme stands out: capital is moving into industries that require hardware, manufacturing, infrastructure, and substantial upfront investment. Those are challenges MedTech already understands.Omar explains why physical AI could bring healthcare into an investment cycle. Surgical robotics, intelligent devices, AI-enabled diagnostics, and specialized automation combine software intelligence with real-world sy...
2026-10-2333 min
State of Medtech424. Space Medicine: Designing Healthcare for Life Beyond Earth with Matthew Kuhn of Skybound MedtechSpace exploration may be approaching a bottleneck: the human body.Omar Khateeb speaks with Matthew Kuhn, CEO of Skybound Medtech, to explore space medicine, autonomous care and robotics.Microgravity accelerates muscle and bone loss, while deep-space communication delays can make real-time support from Earth impractical.They discuss autonomous surgery, physical AI, reusable devices, remote diagnostics, and why space could become an innovation engine for healthcare on Earth.DISCLAIMERThis podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views...
2026-10-191h 04
State of Medtech421. Career: Omar M. Khateeb on building a career in medtech, the state of venture capital and moreIn this episode, Jacob McLaughlin welcomes Omar Khateeb for a conversation about medical device sales, MedTech leadership, entrepreneurship, market strategy, and building long-term career leverage.Omar shares how his career evolved from surgical robotics and medical device sales into marketing, Silicon Valley, entrepreneurship, and MarketCraft, where he focuses on MedTech market engineering for early-stage companies.A central theme is personal ownership. Omar argues that professionals should not wait for a promotion before learning how leaders think. Studying management, business economics, commercialization, strategy, and decision-making early can change the opportunities available later.Jacob and...
2026-10-071h 28
State of Medtech419.MedTech Venture Growth: Becoming Magnetic to Capital, Clinicians and TalentIn this solo episode, Omar Khateeb explains why MedTech founders should stop treating social media like traditional marketing and start using it as a market engineering tool to build investor demand, clinical credibility, strategic awareness, and talent attraction.Most companies begin outreach only when they need something. Investors hear from the company during a fundraise, physicians when adoption matters, recruiters when talent is needed, and strategics when partnerships or exits become relevant.Omar argues for a different model: build familiarity and belief before the ask arrives.That means aligning the founder’s vision, cl...
2026-09-3021 min
State of Medtech417. Unlocking Capital for Medtech Through QSBSIn this solo episode, Omar Khateeb explores why QSBS could become an overlooked capital formation tool in MedTech.QSBS was created to encourage investment in small American businesses, and Omar explains why it may fit MedTech investing well.Medical device companies often require years of engineering, clinical development, FDA review, reimbursement, manufacturing, and commercialization before investors see liquidity. Those timelines can put MedTech at a disadvantage against fast sectors. QSBS offers another way to think about that patience.Omar explains how qualifying investors may exclude portions of eligible federal capital gains after longer...
2026-09-2330 min
State of Medtech416. Venture Capital: Aneta Sottil of Andera Partners on Building MedTech Companies Investors Can ScaleIn this episode, Omar Khateeb speaks with Aneta Sottil, Partner at Andera Partners, about what makes a MedTech company investable as the investment bar continues to rise.Aneta explains why early data is often no longer enough. Investors increasingly want stronger clinical validation, a clear path to market, reimbursement strategy, and proof that a technology can meaningfully improve patient care. She also explains the must-have vs nice-to-have test, why hardware matters, and why founder-investor alignment can shape commercialization and long-term value.The conversation covers MedTech M&A, strategic buyers, surgical robotics, BCI, neuromodulation, wearable cardiac...
2026-09-211h 04
State of Medtech415. Urology Venture Capital: AUA Nexus with Gavin Leonard of MedTech Syndicates and Steven Kaplan MD of the American Urological AssociationExplore Showpad's VIP event, Excellence in the Field, in New York on October 8, 2026, for revenue leaders seeking practical AI and sales insights. Learn more.In this episode, Omar Khateeb speaks with Gavin Leonard, CEO of MedTech Syndicates, and Steven Kaplan, Director of the American Urological Association Innovation Nexus, to explore how clinical insight, capital and commercialization can move MedTech ideas toward patient impact.Steven shares how Nexus connects founders, clinicians, investors and strategics. Roughly 60 companies that presented over three years have collectively raised approximately $570 million. Gavin explains how clinicians can spot unmet...
2026-09-171h 02
State of Medtech412.This Month in MedTech: Physical AI, Strategic M&A and the Evolution of Intelligent Medical DevicesIn this episode of This Month in MedTech, Omar Khateeb speaks with Henry Peck, CBO at LSI | Intelligence, about the technologies, deals, and shifts shaping MedTech.They examine Vitestro’s FDA authorization for autonomous blood draws, bringing physical AI into a high-volume workflow within the roughly $220 billion clinical laboratory services market. The technology could expand capacity, improve access to testing, and allow professionals to oversee multiple automated systems.Omar and Henry also break down 13 deals totaling about $4 billion, consolidation among smaller public companies, and Boston Scientific’s $14.5 billion Penumbra acquisition. Is public MedTech separating into glob...
2026-09-0353 min
State of Medtech410. Physical AI Could Make MedTech the Next Big AI OpportunityIn this solo episode, Omar Khateeb examines why healthcare could become one of the most important beneficiaries of the next phase of AI, even as investors increasingly view the sector as a defensive alternative to the AI infrastructure trade.The central distinction is between building intelligence and deploying intelligence. Healthcare already produces enormous amounts of medical imaging, ECG data, procedural video, robotic data, longitudinal patient information, and continuous physiological signals, yet the industry has historically struggled to extract value from that information at scale. Omar explores how AI could change that equation across radiology, cardiology, surgery, monitoring...
2026-08-2645 min
State of Medtech408. Travis Kalanick’s Lessons on Fundraising, Scale and Resilience for MedTech FoundersIn this solo episode, Omar Khateeb translates some of Uber founder Travis Kalanick’s strongest lessons on fundraising, scale, leadership, and resilience into practical ideas for MedTech founders.The discussion begins with a powerful operating principle: companies can only scale as quickly as their organizations can solve the problems created by growth. FDA clearance, new indications, commercialization, international expansion, and larger sales teams may look like progress, but every milestone also introduces new operational complexity. Omar then examines Travis’s fundraising philosophy and why creating alternatives can matter more than becoming emotionally attached to valuation. For MedTech foun...
2026-08-1938 min
State of Medtech406.Why Most MedTech Investor Decks Fail and What Actually PersuadesWatch Omar’s Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNfJoin Omar at Medtech CEO Camp in Boston. Use code MC1000 for $1,000 off. https://www.campcuriae.com/In this solo episode, Omar Khateeb explains why most MedTech investor decks fail to create conviction and how founders can build presentations that make the market opportunity, adoption path, and use of capital clear.A strong pitch deck is more than a sequence of product, market, competition, team, and financial slides. It is an exercise in market engineering an...
2026-08-1251 min
State of Medtech404.Peter Thiel's Company Building Framework Every MedTech Founder Should MasterIn this solo episode, Omar Khateeb examines Peter Thiel’s most overlooked lesson for MedTech founders: breakthrough technology does not create its own path to customers, investors, clinicians, or commercial adoption.Drawing from the sales and distribution chapter of Zero to One, Omar explains why commercialization begins long before FDA clearance or product launch. A MedTech company is already selling when it recruits employees, raises capital, engages physician advisors, secures clinical partners, and asks hospitals to support a future that has not yet been fully proven.The discussion explores why genuinely innovative technologies require sophisticated ma...
2026-08-0541 min
State of Medtech403.How Mike Minogue Built Abiomed Into a $17B MedTech Unicorn and Now Wants to be Massachusetts' Next GovernorMichael Minogue, 2026 Republican Endorsed Candidate for Governor of Massachusetts, President and CEO of Minogue Consulting, and former CEO of Abiomed, joins Omar Khateeb to share the leadership principles behind one of MedTech's most remarkable growth stories.The conversation explores how Abiomed evolved from a struggling company into a $17 billion MedTech leader by creating an entirely new category around heart recovery rather than competing within an existing market. Michael explains how leadership, commercialization, physician adoption, innovation, culture, disciplined execution, and patient first thinking combined to establish a new global standard of care while delivering extraordinary clinical and business...
2026-08-0348 min
State of Medtech402. Market Engineering and the Science Behind MedTech Category LeadershipIn this episode, Omar Khateeb explores why commercialization is not a launch event but a long-term process of engineering market belief. Strong technology, FDA clearance, clinical validation, and venture funding reduce technical risk, yet they do not guarantee that physicians, investors, or strategic acquirers will change their behavior. The discussion introduces the principles of Market Engineering, the Traction Gap, and Category Design, explaining how successful MedTech companies deliberately build credibility, investor confidence, physician advocacy, and repeatable adoption before expecting commercial scale. Omar also examines why category leaders capture the majority of economic value, why attention should never...
2026-07-2925 min
State of Medtech399. Why MedTech Needs a Bubble to Create the Next Trillion Dollar IndustryInnovation rarely arrives through incremental improvements.It emerges when industries become willing to fund thousands of parallel experiments around a shared vision of the future.In this solo episode, Omar Khateeb explores why productive bubbles have repeatedly accelerated humanity's greatest technological breakthroughs and why MedTech may need its own period of ambitious experimentation to unlock the next generation of category defining companies.Drawing lessons from semiconductor history, Silicon Valley, structural heart, robotics, AI, and healthcare, Omar explains why bubbles should be measured by the infrastructure, knowledge, talent, and capabilities they leave behind rather than the...
2026-07-1550 min
State of Medtech395.This Month in MedTech: Medtronic's Double Bet, a New Heart Valve Market & $92M for Male Birth ControlThis Month in MedTech What the Biggest MedTech Deals Reveal About the Future of Healthcare.June delivered one of the clearest signals yet about where MedTech strategy is heading.In this episode, Omar Khateeb speaks with Henry Peck, Chief Business Officer at LSI, about the deals, investment patterns, and strategic decisions defining the current MedTech market.The discussion covers Medtronic’s two same-day ICE catheter investments across California and Shenzhen, Edwards Lifesciences’ move to own both surgical and transcatheter options in tricuspid, Contraline’s major financing in male contraception, and the accelerating use of AI to pre...
2026-07-0156 min
State of Medtech387. This Month in MedTech: Q1 Earnings, M&A Momentum, and the Rise of Focused StrategicsIn this episode of This Month in MedTech, Omar Khateeb speaks with Nicholas Talamantes, Sr. Director at Life Science Intelligence, about the market signals shaping MedTech right now.The discussion covers Q1 earnings from major strategics, the rise of focused growth platforms, Boston Scientific’s $1.5B bet on structural heart, and the latest M&A activity from J&J, Medtronic, ResMed, Roche, and Artivion.Omar and Nicholas also break down why focus is being rewarded in public markets, why large platforms are divesting non-core assets, and how commercial proof, option structures, and tuck-in acquisitions are shaping the next wave of...
2026-06-031h 22
State of Medtech379. This Month in MedTech 2026: Cardiovascular M&A, Medtronic’s $100M Bet, and the Platform WarsIn this episode of This Month in MedTech 2026, April brings a sharper look at where the market is heading.The discussion covers Medtronic’s $100M investment in Pulnovo, why denervation may be turning into a platform strategy, and how China market access could become a bigger part of global MedTech dealmaking. The episode also unpacks Q1 funding trends, cardiovascular M&A, and key deals across thrombectomy, oncology, metabolic disease, lung cancer, and wearable robotics. The bigger message is clear: capital is still moving, but it is becoming more strategic.This podcast is for informational an...
2026-05-0651 min
State of Medtech377. Exits: 7 Lessons from $17B in Medtech Exits That Every Founder Must KnowIn this episode, Omar Khateeb, Founder of Marketcraft, shares a focused breakdown of how MedTech companies build toward strong exits. Based on $17B in acquisition insights, this solo episode reframes exits as outcomes of deliberate strategy, not last-minute negotiations. Omar highlights how founders create leverage through early acquirer relationships, clear category positioning, and sustained market presence. He also explains why competitive tension matters, how timing impacts value, and why clinical clarity plays a central role in decision-making. If you want a sharper understanding of how MedTech exits actually happen, this episode gives you a clear and actionable perspective.
2026-04-2937 min
State of Medtech375. Crossing the Chasm and The Technology Adoption Curve for Medtech FoundersIn this episode, Omar Khateeb, Founder of Marketcraft, takes a focused look at technology adoption and what it really takes to move from early traction to mainstream scale. This solo conversation highlights why many companies gain initial momentum but struggle to sustain growth.Omar explains the shift from vision-driven early adopters to pragmatic mainstream buyers, and why this transition requires more than a strong product. He breaks down the importance of category clarity, repeatable systems, and structured demand creation in driving real adoption. If you want a sharper understanding of how growth actually happens in MedTech, this episode gives...
2026-04-2237 min
State of Medtech374. Venture: What MVM Partners Really Wants in a MedTech Company with Kyle DempseyIn this episode, Omar Khateeb sits down with Kyle Dempsey, Partner at MVM Partners, to unpack what makes a medtech company investable. Kyle shares how MVM evaluates opportunities, why commercial traction matters, and what separates strong companies from those that get overlooked. They also explore how strategics think about acquisitions, why differentiation and market size matter, and how investors assess risk across the commercialization journey. If you want a clearer understanding of medtech investing, commercialization, and exits, this episode delivers exactly that.Episode Breakdown:00:00 Why MedTech Wins: Innovation vs Big Strategics
2026-04-201h 08
State of Medtech373.How Market Engineering Gets Medtech Startups FundedIn this episode, Omar Khateeb, Founder of Marketcraft, unpacks the real reason most MedTech startups fail to gain traction. This is not a product problem. It is a market problem.He explains how market engineering helps founders define categories, create demand, and move from early innovation to scalable growth. The conversation covers the traction gap, why product market fit is incomplete, and how unclear positioning leads to failed fundraising and slow adoption. If you want a clearer understanding of traction, commercialization, and growth in MedTech, this episode delivers exactly that.Episode Breakdown00:00...
2026-04-1538 min
State of Medtech372. Corporate Venture: Hikma Pharma's VP Corporate Development & Ventures Lana Ghanem on Investing in MedtechIn this episode, Omar Khateeb sits down with Lana Ghanem, VP of Corporate Development & Ventures at Hikma Pharmaceuticals and Managing Director at Hikma Ventures, to unpack how corporate venture is reshaping MedTech.This is not just about capital. It is about how corporate venture teams think, how they assess opportunities, and why most companies never make it past the first conversation.Lana explains why strong traction alone is not enough, and how founders who understand strategic alignment and investor priorities create a clear advantage. The conversation also touches on Hikma’s focus on AI diagnostics, drug development, an...
2026-04-1333 min
State of Medtech369. This Month in MedTech: What Q1 2026 Reveals About Where the Market Is GoingIn this episode, Omar Khateeb speaks with Nicholas Talamantes about the key medtech shifts shaping Q1 2026. They discuss rising M&A activity, the growing neurovascular arms race, and how robotics is evolving to meet ASC demand. The conversation also covers why strategic buyers are prioritizing precision over scale, along with insights on commercialization, investor expectations, and what startups must demonstrate to show real market traction.Episode Breakdown:00:00 Opening Hook: MedTech Market Shift + Stroke Access Crisis00:44 Quick Intro + Industry Context01:05 Welcome to This Month in MedTech (LSI USA)
2026-04-0148 min
State of Medtech365. Strategics: How Olympus Innovation Ventures Is Building the Future of MedTech Innovation with Abigail Hunter-SyedIn this episode, Omar Khateeb speaks with Abby Hunter-Syed, Director at Olympus Innovation Ventures, about how corporate venture capital is accelerating MedTech innovation. Abby shares how they invest in early-stage healthcare startups across endoscopy, diagnostics, GI health, and digital health, and how corporate venture helps founders navigate clinical validation, regulatory approval, and commercialization. They also discuss how investors evaluate early-stage MedTech companies and the signals that indicate future success.Episode Breakdown: 00:00 Intro and Today’s Topic01:08 Meet Abby Hunter-Syed and Olympus Innovation Ventures02:16 Abby’s Non-Linear Career Path into...
2026-03-1149 min
The Orange Tree MedTech Podcast4 MedTech Exits Over $5.2 Billion, 7 Boards, Ray Cohen's Winning Formula for SuccessIn this Orange Tree MedTech Podcast episode, Scott Johnson speaks with accredited public company director, independent board member and venture partner, Ray Cohen. Ray has engineered four blockbuster exits totaling over $5.2 billion: Vessix Vascular, Inc. ($425 million), Axonics, Inc. ($3.7 billion), SoniVie Ltd ($600 million), and Nalu Medical, Inc. ($533 million)—where he served as CEO or Chair. With seven current board seats spanning cutting-edge startups to established players, Ray's fingerprints are all over the industry's most transformative innovations, from neurostimulation to diagnostics. We dive into what it really takes to build, scale, and cash out in MedTech—raw, no-fluff insights from someone who's done i...
2026-03-091h 11
Let's Talk Risk! PodcastLTR 146: Ganesh Sabat on Scaling MedTech Through QualitySummary“A company can become world class the day the quality team decides.”In this Let’s Talk Risk! conversation, host Naveen Agarwal engages with Ganesh Sabat, former former CEO of Sahajanand Medical Technologies (SMT) and now Founder & Managing Partner of MedArtha Capital about a simple but hard truth: global scale in MedTech is earned through quality execution, not marketing narratives.Ganesh walks through SMT’s transformation from an innovative startup into a globally recognized cardiovascular device company, then zooms out to India’s broader MedTech ambition. We unpack what’s missing (talent depth, share...
2026-03-0625 min
The Crux of MedtechBuilding Acquisition-Ready Medtech from Series A with Gautam KainthIn this episode, host Henry Norton sits down with Gautam Kainth, Partner at TCP Health Ventures, to unpack why medtech investing fundamentally differs from traditional tech and what founders need to know about positioning their companies for strategic exits.Gautam brings over 20 years of investment experience with $1+ billion in deployed capital across 30+ transactions spanning the US, Europe, Asia, and Africa. He leads TCP's medtech investments and currently serves on the boards of Tioga Cardiovascular, Adona Medical, and Plexaa, with active oversight of a 12-company portfolio.He shares TCP's playbook for deploying over $220 million across three...
2026-03-0348 min
State of Medtech355.US Surgical: The History of Leon Hirsch and Medtech's Most Infamous CompanyOmar Khateeb, Founder of MarketCraft, reveals the untold story of US Surgical and its founder Leon C. Hirsch, a high school graduate who turned a Russian surgical device into a billion-dollar empire.This episode traces the explosive rise, the brutal "Organ Grinder" sales training, the culture of "feeding eagles and starving turkeys," and the fateful mistake that led to a dramatic downfall.Learn how US Surgical’s dispersed legacy built the foundations of Intuitive Surgical, J&J, and Medtronic, and shaped the entire medtech industry as we know it.If you’re in heal...
2026-02-1037 min
State of Medtech353.Venture: Diego Serrano Cabrera On Venture, Writing and How to Build a Profitable Medtech CompanyIn this episode, Diego Serrano Cabrera, MedTech investor, joins Omar Khateeb for a deep dive into the realities of medtech investing. They explore the critical gap between a brilliant clinical product and a scalable business, why distribution efficiency is the ultimate make-or-break, and how writing can sharpen your investment thesis. Diego opens up about his journey from M&A advisory to growth equity, his philosophy on founder-friendly, long-term capital, and why curiosity compounds in a complex industry. Tune in for an authentic discussion on bubbles, AI’s role in surgery, and how to build genuine relationships in a world of...
2026-01-301h 19
State of Medtech347: This Month in Medtech Dec 2025: Single-Use Robot Breakthrough, Freenome's $330M SPAC, and Edwards' Strategic Move.In this episode, Nicholas Talamantes, Senior Director of Market Intelligence at Life Science Intelligence, joins Omar Khateeb to dissect December 2025's most impactful medtech moves. Wrapping up with a speed round of the month’s top deals, this episode delivers the insights you need to navigate the start of 2026. Press play for the full analysis.Episode Breakdown:00:00 – Cold Open: Fraud, Capital Waste & the Future of Medtech01:38 – Welcome to This Month in Medtech (December Edition)03:00 – December Market Overview & 2025 Trends Recap05:50 – Capital Discipline, IPOs & M&A Momentum08:40 – Early-Stage Funding, Grants & Gov...
2026-01-0859 min
State of Medtech346:The 2026 MedTech Exit Playbook: How Spin-Outs Like DePuy Synthes Are Changing M&A Forever.In this episode Omar Khateeb, Founder of MarketCraft, breaks down the biggest trend reshaping MedTech in 2026: the explosion of "Mini-Strategics." These multi-billion dollar, pure-play spin-outs from giants like J&J and 3M are becoming focused acquirers, finally addressing the industry's chronic exit and liquidity problem. Omar explains how this creates a virtuous cycle, unlocking capital for earlier-stage risk and bolder innovation. He then provides founders with a concrete, 5-step playbook to build leverage, engineer their market category, and position their company as an inevitable acquisition target. Packed with insights on capital allocation, market narratives, and tactical GTM strategy, this...
2026-01-0532 min
Project MedtechEpisode 244 | Michael Challenor, Director of Innovate Medtech | Navigating MedTech Startups and Australia's EcosystemDuane Mancini chats with Michael Challenor to discuss his entrepreneurial journey in the medtech industry, starting from his early passion for invention through his pivotal experiences in the Stanford Biodesign program in Perth, to co-founding Vital Trace. He highlights his current venture, Innovate Medtech, which supports medtech startups with grants, fundraising, and product development. Michael shares valuable insights into the Australian medtech ecosystem, the significance of team and culture, and offers crucial advice for aspiring medtech entrepreneurs. Michael Challenor LinkedInInnovate MedtechAusMedtech 2026Duane Mancini LinkedIn...
2026-01-0551 minProject MedtechEpisode 243 | Spencer Jones, Founder of XO Medtech | Building Community and Accelerating Innovation in MedtechDuane Mancini interviews Spencer Jones, a registered nurse turned medtech entrepreneur. Spencer recounts his journey from bedside nursing to founding two medtech companies, sharing valuable advice on navigating the often complex medtech landscape, including the critical role of thorough customer discovery and strategic vendor relationships in mitigating commercial risks. He also introduces XO MedTech, a training and community platform for medtech innovators, and MedTech Vendors, an AI-driven platform designed to connect medtech teams with ideal service providers. Spencer Jones LinkedInXO MedtechMedtech VendorsDuane Mancini LinkedIn
2025-12-2951 min
The MedTech Unplugged PodcastAMA | Top 3 Interview Mistakes Costing MedTech Candidates the JobYou can be qualified, prepared, and experienced, and still not get the job. In this Ask Me Anything episode of MedTech Unplugged, we break down the three interview mistakes that cost qualified MedTech candidates job offers, even when the interview feels like it went well.This conversation focuses on MedTech interviews and MedTech hiring decisions across medical device, biotech, and healthcare technology roles. We unpack what hiring managers are actually listening for during interviews, why strong candidates become forgettable, and how interview behavior, not resumes, often determines who moves forward.You will learn how interview...
2025-12-2503 min
State of Medtech339.This Month in Medtech: $21B Deals, Cardiovascular Boom & AI SurgesIn this episode, Nicholas Talamantes, Sr. Director of Market Intelligence at Life Science Intelligence (LSI), breaks down the transformative end to 2025 in medtech. We dissect the M&A surge, the critical trends in cardiovascular innovation, and the Q3 earnings that signal a blockbuster 2026. Tune in for the strategic insights every founder and investor needs.Episode Breakdown00:00 – Opening Message: Focus, Confidence & Medtech Momentum 00:56 – Welcome Back: This Month in MedTech (November Edition) 02:00 – Thanksgiving Week Stories & Book Recommendations 03:25 – AI Boom or Bubble? Market Signals & Big Players Moving 06:00 – Tech Bubble Talk: Nvidia, Pala...
2025-12-031h 01The MedTech Unplugged PodcastFrom Concept to Creation: Dr. Leyla Sabet on Innovation & Careers in MedTechJoin MedTech Unplugged as Dr. Leyla Sabet from Abbott shares how medical device ideas become real clinical solutions. She breaks down electrophysiology, product development, and the skills top MedTech teams look for. A must-listen for students, new grads, and professionals exploring careers in the medical device industry.MedTech, medical device industry, medical devices, Abbott, electrophysiology, cardiac EP, MedTech careers, MedTech jobs, engineering careers, biomedical engineering, clinical specialist, product development, healthcare technology, innovation in MedTech, early career MedTech, how to get into MedTech, healthcare careers, life sciences careers, MedTech education, medical technology trends
2025-11-2552 min
State of Medtech337. Biz Dev: Inside the Mind of a MedTech Buyer: A Conversation with Brent Lavin of BD.Brent Lavin, Director of Strategic Growth at BD, joins the show to break down the art and science of medtech M&A. Discover the three key characteristics that determine whether a company builds new tech organically or acquires it and why most get it wrong. He shares real-world stories from acquisitions like Straub Medical and Close, including surprises that only show up after the deal is done. Plus: why startups must now plan for global regulatory hurdles from day one, how to use data for hyper-targeted commercial launches, and the leadership books that shaped his career. Essential listening for any...
2025-11-2448 min
Let's Talk Risk! PodcastLTR 132: Bijan Elahi on Future of MedTech Safety and the 2026 Conference in BostonSummary“This conference is really by the community and for the community - a place where people passionate about MedTech safety can come together to share ideas, learn, and make a difference.”In this Let’s Talk Risk! conversation, host Dr. Naveen Agarwal welcomes back renowned safety risk management expert Bijan Elahi to discuss the upcoming International MedTech Safety Conference 2026 in Boston.Bijan shares the inspiring story of how a grassroots effort among passionate professionals has grown into a global movement for advancing safety risk management in medical devices. From its beginnings at Medtro...
2025-11-1427 minThe MedTech Unplugged PodcastAMA | Breaking Into MedTech Without an Internship (with Jenny Adamou)Ever wondered how to break into MedTech when you don’t have an internship or direct industry experience? In this AMA episode, Jenny Adamou, founder of Navro MedTech Recruiting, answers one of the most common questions from university students and recent grads: How do I get noticed without experience?Jenny breaks down actionable ways to prove initiative, demonstrate technical curiosity, and build your credibility through side projects and LinkedIn visibility. You’ll also learn how hiring managers in the MedTech industry actually evaluate early-career candidates — and how you can position yourself for success before your first role.🎯...
2025-11-0607 min
MedTech ON AIRCutting carbon, saving lives: Harnessing medtech innovation and competitiveness for healthcare decarbonisationHealth drives our lives, from our personal well-being to the health of our planet and economy. On the road to UN Climate Change Conference COP30 in Belém (Brazil), taking place from 10-21 November 2025, we shine a critical spotlight on harnessing medical technology innovation for healthcare decarbonisation.
In this episode of MedTech ON AIR, we are joined by Sigrid Linher, MedTech Europe’s Director for Sustainability and Environment, to discuss the recent MedTech Europe study report commissioned to Boston Consulting Group on “Decarbonising Healthcare: How a Competitive MedTech Industry Can Contribute”.
The episode looks into what inspired MedTech Europe to launch th...
2025-11-0511 min
State of Medtech331. This Month in Medtech: Boston Sci’s new billion dollar venture, J&J’s ortho spinout plus LSI's Compass Reveals Q4 Hot 25October in MedTech was wild billion-dollar deals, bold spinouts, and the future of incision-free surgery.Omar Khateeb and Nicholas Talamantes, Senior Director of Market Intelligence at Life Science Intelligence break down how Boston Scientific, J&J, and Stryker are reshaping the field plus which startups made LSI’s Hot 25 list.Listen in for the market moves, investor insights, and tech shifts defining healthcare’s next decade.Episode Breakdown00:00:00 Cold open & state of MedTech: hardware, AI, incisionless surgery00:00:53 Host banter October, pumpkin patch moment00:01:29 Quick banter return...
2025-11-031h 05The MedTech Unplugged PodcastHow to Break Into MedTech with Catherine Yankelevich | MedTech UnpluggedIf you’re a student or recent grad looking to launch a career in the medical technology industry, this episode is for you. Catherine Yankelevich, Divisional VP at Boston Scientific, joins host Dino from Navro to share how she began as an MBA intern and built a successful MedTech career — and the lessons that can help new engineers, biology majors, and business students do the same.Topics include:• Building transferable skills for MedTech roles • Transitioning from research or technical positions to business or commercial paths • H...
2025-10-2856 min
State of Medtech324. Sales: Using AI to Close More Deals in MedTech with Omar Khateeb & Showpad's Chris KosrowAre you a medtech sales leader? Try the Showpad AI Sales Enablement Maturity Calculator to measure team fitness across four key areas – and get tailored feedback. https://showpad.com/enablement-maturity-calculator-start/#/AI won’t replace your job… but someone using AI will. In this powerful episode, Showpad’s Chris Kosrow joins Omar M. Khateeb to explore how AI is revolutionizing the way MedTech sales teams operate, sell, and scale.This episode dives deep into how AI tools like Showpad Assist are changing the sales game in MedTech. Chris Kosrow, Director of New B...
2025-10-1855 minThe MedTech Unplugged PodcastBreaking Into MedTech: Real Questions from Students, Graduates, and Industry ProfessionalsWelcome to MedTech Unplugged, powered by Navro — the home for careers in medical technology.In this first Ask Me Anything (AMA) episode, host Jenny Adamou answers real questions from students, recent graduates, and early-career professionals who want to break into the MedTech industry.From understanding what hiring managers are really looking for to figuring out how to network, identify your ideal MedTech sector, and make your experience stand out — this episode dives deep into the questions you’ve always wanted to ask.In this episode, you’ll learn:How to get noticed by MedTe...
2025-10-1517 min
State of MedtechThis Month in Medtech: Build to Buy, Heartflow IPO, Strategics on the MoveFrom billion dollar M&A to FDA greenlights and the next wave of surgical AI, August was packed with major stories in medtech. Omar Khateeb & Nicholas Talamantes break down the month’s biggest moves, from Philips’ restructuring and Medtronic’s AI milestone to emerging neurotech players and investor trends shaping the rest of 2025.Episode Breakdown:00:00 Medtech is back: August + September recap 01:05 Omar’s new baby & the team’s European summer break 03:42 The $500 million quarter that proved Medtech’s engine is alive 05:09 Inside LSI’s Hot 25 Startups – how they rank th...
2025-10-081h 11
State of MedtechStartups: Avoiding the Biggest Startup Mistakes with Paul Grand, CEO of MedTech InnovatorWhat does it take to build a medtech startup that actually survives? Paul Grand, CEO and Founder of MedTech Innovator, has seen more than 14,000 companies apply to his program and helped over 800 raise billions in capital.In this episode, Paul joins Omar Khateeb to break down the top mistakes founders make, how investors really assess risk, why commercialization is the true valley of death, and what trends are shaping the next generation of medtech innovation.Episode Breakdown:00:00 – Introduction: Challenges of the MedTech space01:19 – Guest introduction: Paul Grand, CEO & Founder of MedTech Inno...
2025-10-0200 min
Let's Talk Risk! PodcastLTR 125: Kevin Schawinski on Building Trustworthy AI and MedTech ReadinessSummary“EU MDR is the spiritual ancestor of the EU AI Act”.In this Let’s Talk Risk! conversation, host Naveen Agarwal welcomes Kevin Schawinski, astrophysicist turned AI entrepreneur and CEO of Modulos AG. Kevin shares his journey from studying black holes to building AI governance solutions, and explains how the EU AI Act is modeled after the EU Medical Device Regulation (MDR). He highlights the parallels between product safety regimes in MedTech and emerging AI regulation, offering practical insights for organizations preparing for compliance.The conversation explores ISO 42001 as a baseline AI manage...
2025-09-2627 min
State of MedtechVenture: Armen Vidian on Rethinking Medtech VC and AI Enabled DevicesVenture capital veteran Armen Vidian joins Omar Khateeb to discuss the future of medtech investing, the missing link between tech and healthcare, and what today’s founders must do to attract capital and talent. From the challenges of clinical trials to the opportunity in AI-enabled devices, this conversation dives into the realities of building, funding, and scaling medtech companies in a shifting landscape.Episode Breakdown:00:00 Students of the market and what defines great founders01:32 Armen Vidian’s journey from Racine to MIT to medtech05:00 Lessons from Evolve and Abbo...
2025-09-221h 06Project MedtechEpisode 233 | Kevin Saem, Managing Director at Zapyrus | The Future of MedTech: Data-Driven Decisions & Investment InsightsIn this episode, Duane Mancini welcomes back Kevin Saem, Managing Director of Zapyrus, for an enlightening discussion on the future of the MedTech industry. The episode delves into the latest trends in medtech funding, highlighting a significant increase in investments outside the U.S., the pivotal role of diagnostic technologies, and the importance of clinical data over revenue for attracting investments. Kevin shares groundbreaking advancements in data analytics and predictive machine learning applications, helping medtech companies and service providers enhance their commercialization strategies and efficiency. Kevin Saem LinkedInZapyrus Website...
2025-09-2254 minProject MedtechEpisode 229 | Jessica Richter, Medtech Executive & Board Member, MedtechWOMEN | Navigating the Medtech Landscape: Sales, Leadership, and Women in MedtechIn this episode, Duane Mancini welcomes to the show Jessica Richter, a seasoned medtech executive and board member of MedtechWOMEN. With over 20 years in the industry, Jessica shares her extensive career journey from a medical device sales rep, through various leadership roles at companies like Medtronic, to her current independent consulting role. The discussion covers vital topics such as navigating the US healthcare market, effective sales strategies, the importance of stakeholder alignment, and tips for early-stage entrepreneurs transitioning into leadership roles. Jessica also highlights the critical role of diversity in medtech and shares insights on the mission and initiatives...
2025-08-2552 min
State of MedtechJuly Medtech Recap: Q2 Earnings, Deals, and Robotic EndoscopyStrong earnings, mega-deals, and a robotics shake-up highlight medtech’s Q2. Nicholas Talamantes joins to cover the numbers, the moves, and the strategies setting the tone for the second half of the year.Episode Breakdown:00:00 – Opening and show introduction01:02 – Meet guest Nicholas Talamantes and episode agenda02:02 – Q2 earnings overview and market growth05:15 – Spin-outs, mega-deals, and the venture ecosystem08:39 – Key takeaways from a strong Q209:01 – Trade policy, tariffs, and AI regulation14:25 – Trending stories: cardiology leads funding16:57 – Acquisitions and diagnostics momentum19...
2025-08-1800 min
Let's Talk Risk! PodcastLTR 114: What QA/RA Professionals Need to Know About Rapidly Growing MedTech in IndiaSummary“MedTech in India is poised to generate $50 billion in revenues by 2030.”In this Let’s Talk Risk! conversation, host Naveen Agarwal engages with Sanjay Arudi, VP of Regulatory and Quality at GE Healthcare in India, to discuss the rapidly evolving MedTech environment in India. They explore the current state of the MedTech industry, government initiatives supporting healthcare, the regulatory landscape, and the importance of post-market surveillance. Sanjay shares insights on the challenges faced in regulatory compliance and offers career advice based on his extensive experience in the field. The conversation highlights India's potential to become...
2025-07-1131 min
State of Medtech292. June in Medtech: $700M in Deals, Medtronic’s Strategic Exit & LSI HighlightsEpisode breakdown:00:00 – What June’s headlines missed 01:44 – Why Medtronic exited another business unit 05:02 – The quiet strategy behind “focus” 08:20 – $700M in deal volume: Who’s buying, who’s scaling 09:56 – LSI 2024: What we learned on the ground 13:33 – GTM strategy shifts in diagnostics and devices 15:41 – Private equity’s next move in medtech 18:23 – Boston Scientific’s bet and others to watch 20:10 – Key signals investors are paying attention to 22:50 – Where AI is winning—beyond the hype 26:17 – Medtech’s Q3 setup: what matters next**Learn more about LSI’s mark...
2025-07-1058 min
State of Medtech290. Tech’s Answer to Medtech’s Feedback Problem: A Conversation with Fanvoice Founder Sasi ParthasarathyEpisode breakdown:00:00 – The Hidden Problem in Medtech Feedback 02:16 – From Bing + Netflix to Medtech: Sasi’s Journey 04:17 – The Missing Link in Voice of Customer 08:01 – How Fanvoice Works for Busy Surgeons + Reps 10:17 – Sales as a Strategic Feedback Channel 14:29 – Small Sample, Big Signals: AI Pattern Recognition 16:40 – Sentiment Analysis = Real-Time Product Intelligence 20:22 – Avoiding Slow Burn Failures Through Fast Feedback 26:06 – Consumer-Grade UX Expectations Are Here 28:48 – The Worst Feedback System in Hospitals Today 31:56 – Event-Based Feedback for Early-Stage Startups 34:14 – Automating CRM Insights from the Field 38...
2025-07-0342 min
The Crux of MedtechWhy Most Medtech Fundraisers Fail and What to Do Instead - Kiko Filipov, Partner at APPARIUSRaising capital in Medtech is tougher than ever. Investor expectations have shifted. Competition is up. And many founders are still pitching like it’s 2018.In this episode, Henry Norton sits down with Kiko Filipov, Partner at APPARIUS Corporate Finance and Strategic Advisor at Cruxx, to unpack the real mechanics of a successful fundraise in 2025. From first-in-human data to commercial readiness, Kiko shares what separates the rounds that get oversubscribed from the ones that stall.He also explores the changing landscape of Medtech innovation and why strategic exits take years of...
2025-06-2552 min
MedTech ON AIRInsights from The MedTech Forum 2025 - Part 2Special episodes of MedTech ON AIR, live from the MedTech Forum 2025, episode 2
This is part 2, of a two-part special edition of MedTech ON AIR, which was recorded live at the MedTech Forum 2025 in Lisbon. The MedTech Forum is the largest gathering of medical technology industry in Europe.
In the second part of this special series, we continue to unpack the key takeaways from Europe’s leading health and medical technology industry conference. Our guests reflect on the Forum’s most compelling discussions: from patient engagement and women’s health, to the real-world implementation of sustainability, and the integration of diagnostics in cli...
2025-06-1910 min
MedTech ON AIRInsights from The MedTech Forum 2025 - Part 1Special episodes of MedTech ON AIR, live from the MedTech Forum 2025, episode 1This two-part special edition of MedTech ON AIR was recorded live at the MedTech Forum 2025 in Lisbon — the largest gathering of the medical technology industry in Europe.
In these episodes, we explore the MedTech Forum’s role as a pivotal gathering, where the themes and conversations will shape the direction of the medical technology industry for years to come.
Listen in as our guests share their reflections on the MedTech Forum, how Europe can strengthen its position as a global hub for innovation, the growing focus on sustainability, and...
2025-06-1110 min
State of Medtech279. Ray Cohen on Building & Selling Billion-Dollar MedTech Startups Without BankersEpisode breakdown:00:00 – Intro: Ray Cohen’s MedTech Resume 02:21 – 44 Years, 0 BigCo Jobs: Ray’s Founding Philosophy 05:04 – How He Closed a $600M Deal Without an Investment Banker 08:05 – Why Relationships Matter More Than Bankers in M&A 11:19 – When Is the Right Time to Sell a MedTech Company? 13:44 – Why He Took Axonics Public *Before* FDA Approval 15:53 – $111M in Year 1 During COVID — How They Pulled It Off 17:42 – Why Most Commercialization Efforts Fail 19:19 – $230M IPO: How He Built the Case for Kestra’s Public Debut 22:36 – Turning Venture Dollars into...
2025-05-2742 min
State of Medtech277. Inside Intuitive: Gary Guthart on AI, Diagnosis Delays, and Medtech’s FutureEpisode breakdown:00:00 – Why MedTech Still Fails Patients03:19 – The Diagnosis Delay Crisis: Lung, Heart & Endometriosis09:31 – Intuitive’s Vision: Redefining Outcomes Through Technology12:01 – How Intuitive Measures Success: The Quintuple Aim14:56 – Inside Intuitive’s Innovation & Startup Ecosystem21:34 – From Mathematician to MedTech CEO: Gary’s Founder Journey25:50 – Startup Grit: Navigating the AI River in Healthcare29:16 – Leadership & Culture: What Drives Intuitive’s 97% Retention32:33 – Mentorship in MedTech: How to Attract the Right Advisors35:00 – Balancing Stakeholders: Patients, Hospitals, Investors37:53 – AI in Healthcare: Signal vs. Hype, Pipes vs. Math41:40 – Omar Khateeb asks how Intuitive Maintains a Culture of Disruptio...
2025-05-1952 min
State of Medtech251. Career: How to Accelerate Your Career Growth in Medtech with Henry PeckThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.00:00 Introduction to MedTech and Personal Journeys
2025-02-121h 42Project MedtechEpisode 208 | Devon Campbell, Founder, Managing Director at Prodct and Eric O'Dell, Consultant at Project Medtech | Bootstrapping Your Medtech Startup: Essential Finances for FoundersIn this episode, Devon Campbell, Founder and Managing Director at Prodct, and Eric O'Dell, Consultant at Project Medtech, join Duane Mancini in a must-listen for bootstrapped Medtech founders! This episode provides a DIY guide to managing your startup's finances without hiring expensive professionals. Learn how to set up bank accounts, choose the right corporate structure, master basic accounting with QuickBooks and spreadsheets, manage your cap table, and navigate taxes. Tune in for actionable advice and build a strong financial foundation for your Medtech venture, even on a limited budget.
Devon Campbell LinkedIn
Eric O'Dell LinkedIn...
2025-02-0349 min
The Medtech Impact PodcastMedtech Knowledge Community with Spencer Jones of XO MedtechIn this episode, Spencer Jones, Founder of XO Medtech, discusses the problem with innovation silos in medical technology and the commercialization process. Spencer highlights how innovators are often afraid to share information about what they are working on, and this can stifle progression. Additionally, there is a lack of access to open networks for comprehensive practical knowledge transfer related to commercialization.Spencer outlines how XO Medtech’s platform offers a new online community approach for educating and connecting innovators, helping provide them with the resources needed to succeed. This includes a community forum, educational content, and a ra...
2025-01-2430 min
State of Medtech190. Marketing: Best Attribution Practices and Conference Strategies for Medtech companiesThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2024-07-2437 min
State of Medtech188. Marketing: 2024 Medtech Growth StrategiesThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2024-07-181h 03
State of Medtech184. Sales Training with Medtech Veteran Gene NagelThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2024-06-2446 min
State of Medtech171. The Future of Medtech Sales with Steve BellThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2024-04-221h 17
State of Medtech155. How to Get More Surgeon Demos with LinkedIn Ads for MedTech Startups REVISITEDThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2024-02-291h 00
State of Medtech149. Marketing: What's Wrong with MedTech Marketing with Omar M. KhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2024-02-1650 min
State of Medtech141. Venture Capital: Scott Huennekens MedTech 2024 OutlookThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2024-01-291h 05
State of Medtech137: JP Morgan 2024 MedTech HighlightsThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2024-01-1942 min
State of Medtech114. Marketing: How to do Account Based Marketing in MedTech with Tyler PleissThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2023-11-0854 min
State of Medtech110. Sales: How MedTech Companies Can Grow Revenue through Digital Sales with Omar M. Khateeb, Daniel Hawkins, and Kyle ColemanThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2023-10-3040 min
State of Medtech103. AdvaMed MedTech Con 2023 Keynote TakeawaysThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2023-10-1333 min
State of Medtech100. Manifest MedTechThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2023-10-0649 min
Medtech MoneyEpisode 129 | Rich Mazzola, CFO at Project Medtech | Introducing the New Host of the Medtech Money Podcast powered by Project Medtech
In this episode, Rich Mazzola and Duane Mancini discuss Rich's background in the Medtech space, what we can expect from him as host of the Medtech Money podcast series and so much more.
Rich Mazzola LinkedIn
Project Medtech Website
Project Medtech LinkedIn
Duane Mancini LinkedIn
2023-10-0422 minProject MedtechEpisode 155 | Rich Mazzola, CFO at Project Medtech | Introducing the New Host of the Funding Medtech Podcast powered by Project Medtech
In this episode, Rich Mazzola and Duane Mancini discuss Rich's background in the Medtech space, what we can expect from him as host of the Medtech Money podcast series and so much more.
Rich Mazzola LinkedIn
Project Medtech Website
Project Medtech LinkedIn
Duane Mancini LinkedIn
2023-10-0222 min
State of Medtech90. MedTech Women 2023 with Lisa Carmel and Stephanie JonesThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2023-09-0659 min
State of Medtech88. Strategic Deals: MedTech Investor Scott Huennekens on What Large Strategics Should be Looking ForThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsAre you a medtech CEO in need of some marketing...
2023-08-301h 01
State of Medtech60. Crowdfunding: What to Know About Crowdfunding in MedTech with Kevin Morris of Atlas RdThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Are you a medtech CEO in need of some marketing...
2023-06-101h 06
State of Medtech50. Sales: How to Drive MedTech Adoption Using LinkedIn with Ashish Khanna, MDThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Are you a medtech CEO in need of some marketing help attracting...
2023-04-1241 min
State of Medtech47. What Happened with Silicon Valley Bank and How Was MedTech Impacted?This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Are you a medtech CEO in need of some marketing help attracting...
2023-03-1342 minState of Medtech44. Venture Capital: Sofinnova Partners Chairman Antoine Papiernik on 2023 MedTech Venture Capital OutlookThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Are you a medtech CEO in need of some marketing help attracting...
2023-02-1552 minState of Medtech34. Capital Sales: Perfecting the MedTech Capital Sales Process with Ken HustedThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Are you a medtech CEO in need of some marketing help attracting...
2022-11-161h 27State of Medtech33. Leadership: Scott Huennekens on MedTech Entrepreneurship Plus his 2021 LSI Emerging MedTech Investor Summit KeynoteThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Are you a medtech CEO in need of some marketing help attracting...
2022-11-022h 05State of Medtech26. Physicians: How Become a Top MedTech Advisor as a PhysicianThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Are you a medtech CEO in need of some marketing help attracting...
2022-08-311h 27State of Medtech24. Venture Capital: Surgeonpreneur: 3 Keys to Raising Venture Money in MedTech with Jeff Smith of Providence MedicalThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Are you a medtech CEO in need of some marketing help attracting...
2022-08-231h 27State of Medtech21. Marketing: How to Get More Surgeon Demos with LinkedIn Ads for MedTech StartupsThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Are you a medtech CEO in need of some marketing help attracting...
2022-08-011h 04State of Medtech18. Sales: Upending the MedTech Sales Model Panel from LSI Investor SummitThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Are you a medtech CEO in need of some marketing help attracting...
2022-07-0647 min
State of Medtech15. Panel: Web3, NFTs, and Decentralized Science at LSI USA '22 Emerging Medtech Summit with Henry Peck, Scott Pantel, and Omar M. KhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Are you a medtech CEO in need of some marketing help attracting...
2022-06-0959 min
Project MedtechEpisode 87 | Sean Bittner: Director of Programs at M1 Medtech Accelerator | Houston, Texas: The Next Medtech Hub for Startups?
In this episode, Sean Bittner and Duane Mancini discuss the new M1 accelerator in Houston, Texas, their focus in Medtech, importance of partnerships, how fatal choosing the wrong team can be for an early-stage startup, importance of warm introductions, the Houston ecosystem in Medtech, the importance of great leadership, raising too much money, and so much more.
Sean Bittner LinkedIn
M1 Medtech Accelerator Website
Duane Mancini LinkedIn
Project Medtech LinkedIn
Project Medtech Website
2022-04-0438 min
State of Medtech11. How NFTs and Web 3 Will Change MedTechThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Are you a medtech CEO in need of some marketing help attracting...
2022-03-121h 04State of Medtech8. How Physicians Can Start a Career in MedTech with Dr. Qasim Butt MDThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Are you a medtech CEO in need of some marketing help attracting...
2022-02-1655 min
Medtech MoneyEpisode 30: Jennifer McMahon, Principal at Seroba Life Sciences --- Women in Medtech Venture Capital & How Early-Stage European VCs Invest
In this episode, Giovanni and Jen discuss how she got involved in the space, what her fund invests in, contrasting time to exit for Biotech vs. Medtech, failure rates of an investment in Medtech, the MDR and how it is affecting deal flow in Europe, the Medtech ecosystem in Ireland, women in Medtech and more.
Jennifer McMahon LinkedIn
Seroba Life Sciences Website
Giovanni Lauricella LinkedIn
Project Medtech LinkedIn
Project Medtech Website
2021-10-1259 min
Medtech MoneyEpisode 26: Paul Grand, CEO of Medtech Innovator --- How the World's #1 medtech Accelerator Prepares Its Start-Ups for External Capital and Growth
In this episode, Giovanni and Paul discuss Medtech Innovator, how they add value to a start-up company, common errors he used to see in start-up companies, the mechanics of how Medtech Innovator works, how they prepare their companies for external capital and more.
Paul Grand LinkedIn
Medtech Innovator Website
Giovanni Lauricella LinkedIn
Project Medtech LinkedIn
Project Medtech Website
2021-09-291h 09
Project MedtechMedtech Money --- Episode 42: James Biggins, CEO at Access Vascular --- Founder Raises Series B: R&D to Commercialization --- The Full Spectrum of Medtech
In this episode, Giovanni and James discuss creating a culture at a start-up that people want to be a part of, how he founded Access Vascular, why doing sales was important for his success as a Medtech CEO, the ability to find and fill the gaps as a Medtech startup, how he raised money for Access Vascular, his tips for Medtech companies for overall success and success in raising capital, and more.
James Biggins LinkedIn
Access Vascular Website
Giovannia Lauricella LinkedIn
Project Medtech LinkedIn
Project Medtech Website
2020-05-071h 01
Project MedtechMedtech Money --- Episode 30: Jennifer McMahon, Principal at Seroba Life Sciences --- Women in Medtech Venture Capital & How Early-Stage European VCs Invest
In this episode, Giovanni and Jen discuss how she got involved in the space, what her fund invests in, contrasting time to exit for Biotech vs. Medtech, failure rates of an investment in Medtech, the MDR and how it is affecting deal flow in Europe, the Medtech ecosystem in Ireland, women in Medtech and more.
Jennifer McMahon LinkedIn
Seroba Life Sciences Website
Giovanni Lauricella LinkedIn
Project Medtech LinkedIn
Project Medtech Website
2020-05-0759 min
Project MedtechMedtech Money --- Episode 29: Gaston Vasseur, Investment Manager at Anaxago --- Insight into Early-Stage Medtech and Digital Health Venture Capital in France
In this episode, Giovanni and Gaston discuss early stage investments in Medtech, how they invest on a deal by deal basis through network of investors, the Medtech scene in France and Europe as a whole, filling the gap in France between early stage investors and late stage investors, how the French government is supporting innovation, how the MDR is affecting Medtech deal flow, and more.
Gaston Vasseur LinkedIn
Anaxago Website
Giovanni Lauricella LinkedIn
Project Medtech LinkedIn
Project Medtech Website
2020-05-0752 min
Project MedtechMedtech Money --- Episode 26: Paul Grand, CEO of Medtech Innovator --- How the World's #1 Medtech Accelerator Prepares Its Start-Ups for External Capital and Growth
In this episode, Giovanni and Paul discuss Medtech Innovator, how they add value to a start-up company, common errors he used to see in start-up companies, the mechanics of how Medtech Innovator works, how they prepare their companies for external capital and more.
Paul Grand LinkedIn
Medtech Innovator Website
Giovanni Lauricella LinkedIn
Project Medtech LinkedIn
Project Medtech Website
2020-05-071h 09Project MedtechEpisode 243 | Spencer Jones, Founder of XO Medtech | Building Community and Accelerating Innovation in MedtechDuane Mancini interviews Spencer Jones, a registered nurse turned medtech entrepreneur. Spencer recounts his journey from bedside nursing to founding two medtech companies, sharing valuable advice on navigating the often complex medtech landscape, including the critical role of thorough customer discovery and strategic vendor relationships in mitigating commercial risks. He also introduces XO MedTech, a training and community platform for medtech innovators, and MedTech Vendors, an AI-driven platform designed to connect medtech teams with ideal service providers. Spencer Jones LinkedInXO MedtechMedtech VendorsDuane Mancini LinkedIn
1970-01-0151 min